Document Type : Original Article


1 Pediatric Hematology and Oncology Department, Ardabil University of Medical Science, Ardabil, Iran.

2 Department of Pediatric, Faculty of medicine, Ardabil University of Medical Science, Ardabil, Iran

3 Center for Cell Pathology Research, Department of Biological Science, Khazar University, Baku, Azerbaijan

4 Department of Community Medicine, Faculty of Medicine, Ardabil University of Medical Science, Ardabil, Iran.

5 Department of Community Medicine, Faculty of Medicine, Ardabil University of Medical Science, Ardabil, Iran

6 Center for Cell Pathology Research, Life Sciences Department, Khazar University, Baku, Azerbaijan.

7 Department of Molecular Genetic, Payam-e-Noor University, Tehran, Iran


Glucose-6-phosphate dehydrogenase (G6PD) is one of the most common genetic deficiencies that affect approximately 400 million people worldwide. This study aimed to identify neonates with G6PD deficiency in Ardabil province during 2017-2018. This cross-sectional study was conducted on all term and preterm newborns in Ardabil Province from April 2018 to April 2019. The sampling method was census and in study duration, 1044 newborns were entered in the study. For each infant, severe hyperbilirubinemia (total serum bilirubin equal or greater than 300 micromol/L) was tested by the diazo method and G6PD was evaluated by Fluorescent Spot Test (FST). Of all infants, 15 (1.4 %) were diagnosed to have G6PD deficiency by FST. The prevalence of G6PD deficiency was significantly in boys higher than in girls (80% vs. 20%, p=0.001). Of all infants, 97 (9.3%) had jaun dice 72 hours after birth that of them 7 neonates (7.2%) had G6PD deficiency. Results showed that the prevalence of G6PD deficiency in this study was less than in other places in Iran that may be because of different ethnicity and demographic features.

Graphical Abstract

Neonatal Screening for Glucose-6-phosphate dehydrogenase Deficiency in Ardabil Province, Iran, 2018-2019


Main Subjects

Selected authors of this article by journal


ِDr. Firouz Amani
Ardabil University of Medical Sciences
ِDr. Irada Khalilova
Khazar University, Baku, Azerbaijan
GoogleScholar(H Index=24); Publons(H Index=8) GoogleScholar(H Index=12); Publons(H Index=9)

Open Access

This article is licensed under a CC BY License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit:


Publisher’s Note

CMBR journal remains neutral with regard to jurisdictional claims in published maps and institutional afflictions.


Letters to Editor

Given that CMBR Journal's policy in accepting articles will be strict and will do its best to ensure that in addition to having the highest quality published articles, the published articles should have the least similarity (maximum 15%). Also, all the figures and tables in the article must be original and the copyright permission of images must be prepared by authors. However, some articles may have flaws and have passed the journal filter, which dear authors may find fault with. Therefore, the editor of the journal asks the authors, if they see an error in the published articles of the journal, to email the article information along with the documents to the journal office.

CMBR Journal welcomes letters to the editor ([email protected], [email protected]) for the post-publication discussions and corrections which allows debate post publication on its site, through the Letters to Editor. Critical letters can be sent to the journal editor as soon as the article is online. Following points are to be considering before sending the letters (comments) to the editor.

[1] Letters that include statements of statistics, facts, research, or theories should include appropriate references, although more than three are discouraged.

[2] Letters that are personal attacks on an author rather than thoughtful criticism of the author’s ideas will not be considered for publication.

[3] There is no limit to the number of words in a letter.

[4] Letter writers should include a statement at the beginning of the letter stating that it is being submitted either for publication or not.

[5] Anonymous letters will not be considered.

[6] Letter writers must include Name, Email Address, Affiliation, mobile phone number, and Comments.

[7] Letters will be answered as soon as possible.

  1. Kilicdag H, Gökmen Z, Ozkiraz S, Gulcan H, Tarcan A (2014) Is it accurate to separate glucose-6-phosphate dehydrogenase activity in neonatal hyperbilirubinemia as deficient and normal? Pediatrics & Neonatology 55:202-207. doi:
  2. Al-Musawi BM, Al-Allawi N, Abdul-Majeed BA, Eissa AA, Jubrael JM, Hamamy H (2012) Molecular characterization of glucose-6-phosphate dehydrogenase deficient variants in Baghdad city-Iraq. BMC blood disorders 12:1-6. doi:
  3. Moosazadeh M, Amiresmaili M, Aliramezany M (2014) Prevalence of G6PD deficiency in Iran, a mata-analysis. Acta medica Iranica 52:256-264
  4. Cappellini MD, Fiorelli G (2008) Glucose-6-phosphate dehydrogenase deficiency. The Lancet 371:64-74. doi:
  5. Ahadi A, Mirzarahimi M, Ahmadabadi F, Tavasoli A, Parvaneh N (2013) Comparison of the efficacy of Clofibrate with Phenobarbital in decreasing neonatal hyperbilirubinemia. Iranian Journal of Neonatology IJN 4:13-19
  6. Tang J, Jiang C, Xiao X, Fang Z, Li L, Han L, Mei A, Feng Y, Guo Y, Li H (2015) Changes in red blood cell membrane structure in G6PD deficiency: An atomic force microscopy study. Clinica Chimica Acta 444:264-270. doi:
  7. Pahlavanzadeh M, Hekmatimoghaddam S, Ardestani MT, Ghafoorzadeh M, Aminorraaya M (2013) G6PD enzyme deficiency in neonatal pathologic hyperbilirubinemia in Yazd. Iranian journal of pediatric hematology and oncology 3:69-72. doi:PMCID: PMC3915450; PMID: 24575273
  8. Mesner O, Hammerman C, Goldschmidt D, Rudensky B, Bader D, Kaplan M (2004) Glucose-6-phosphate dehydrogenase activity in male premature and term neonates. Archives of Disease in Childhood-Fetal and Neonatal Edition 89:F555-F557. doi:
  9. Liu H, Liu W, Tang X, Wang T (2015) Association between G6PD deficiency and hyperbilirubinemia in neonates: a meta-analysis. Pediatric hematology and oncology 32:92-98. doi:
  10. Farhoud D, Yazdanpanah L (2008) Glucose-6-phosphate dehydrogenase (G6PD) Deficiency. Iranian Journal of Public Health 37:1-18
  11. Iranpour R, Hashemipour M, Talaei S-M, Soroshnia M, Amini A (2008) Newborn screening for glucose-6-phosphate dehydrogenase deficiency in Isfahan, Iran: a quantitative assay. Journal of medical screening 15:62-64. doi:
  12. Ghoreyshi S, Soltani AH, Ghoreyshi S (2007) Glucose-6-phosphate dehydrogenase deficiency in Icteric neonates admitted in Tabriz pediatric medical center. Medical Journal of Tabriz University of Medical Sciences 27:89-93
  13. Atay E, Bozaykut A, Ipek IO (2006) Glucose-6-phosphate dehydrogenase deficiency in neonatal indirect hyperbilirubinemia. Journal of tropical pediatrics 52:56-58. doi:
  14. Iranpour R, Akbar M, Haghshenas I (2003) Glucose-6-phosphate dehydrogenase deficiency in neonates. The Indian Journal of Pediatrics 70:855-857. doi:
  15. Kosaryan M, Mahdavi MR, Jalali H, Roshan P (2014) Why does the Iranian national program of screening newborns for G6PD enzyme deficiency miss a large number of affected infants? Pediatric hematology and oncology 31:95-100. doi:
  16. Bhutani VK, Stark AR, Lazzeroni LC, Poland R, Gourley GR, Kazmierczak S, Meloy L, Burgos AE, Hall JY, Stevenson DK (2013) Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. The Journal of pediatrics 162:477-482. e471. doi:
  17. Najib KS, Saki F, Hemmati F, Inaloo S (2013) Incidence, risk factors and causes of severe neonatal hyperbilirubinemia in the South of iran (fars province). Iranian Red Crescent Medical Journal 15:260-263. doi:
  18. Kavehmanesh Z, Ebrahimi-Mohammadieh N, Karimi-Zarchi AA, Amir SS, Z. K-M, Torkaman M (2008) Prevalence of readmission for hyperbilirubinemia in healthy newborns. Iranian Journal of Pediatrics 8:130-136
  19. Bhutani VK, Johnson L, Sivieri EM (1999) Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 103:6-14. doi:
  20. Tiberi E, Latella C, Parenti D, Romagnoli C (2007) Predictive ability of a predischarge hour-specific serum bilirubin for hyperbilirubinemia in full term infants. Minerva pediatrica 59:183-189. doi:PMID: 17519862
  21. Alpay F, Sarici SÜ, Tosuncuk HD, Serdar MA, Inanç N, Gökçay E (2000) The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics 106:e16-e16. doi:
  22. Abolghasemi H, Mehrani H, Amid A (2004) An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates. Clinical biochemistry 37:241-244. doi:
  23. Amoozegar H, Mirshakeri M, Paishva N (2005) Prevalence of Glucose-6-phosphate dehydrogenase deficiency among male donors in Shiraz, southern Iran. Iranian Journal of Medical Sciences 30:94-96
  24. Sinha R, Sachendra B, Syed VS, Nair L, John B (2017) To study the prevalence of glucose 6 phosphate dehydrogenase (G6PD) deficiency in neonates with neonatal hyperbilirubinemia and to compare the course of the neonatal jaundice in deficient versus non deficient neonates. Journal of Clinical Neonatology 6:71-74. doi:
  25. M Abo El Fotoh WM, Rizk MS (2016) Prevalence of glucose-6-phosphate dehydrogenase deficiency in jaundiced Egyptian neonates. The Journal of Maternal-Fetal & Neonatal Medicine 29:3834-3837. doi: